Kava

DRUG5 trials

Sponsors

National Center for Complementary and Integrative Health (NCCIH), Masonic Cancer Center, University of Minnesota, University of Florida

Conditions

AnxietyAnxiety DisordersCancerDepressionKavaKava on the Metabolism of Nicotine and NNKSleepSmoking

Early Phase 1

Effect of Kava on Anxiety and Stress in Cancer Survivors

SuspendedNCT06213298

Masonic Cancer Center, University of MinnesotaAnxiety, Cancer, Depression +3

Start: 2024-06-20End: 2028-11-01Target: 43Updated: 2026-02-11

Phase 1

Exploring the Impact of Two-week Kava on the Metabolism of Nicotine and NNK

WithdrawnNCT03606655

University of FloridaKava on the Metabolism of Nicotine and NNK

Start: 2020-01-31End: 2021-01-31Updated: 2020-01-13

Phase 2

Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)

TerminatedNCT00083980

National Center for Complementary and Integrative Health (NCCIH)Anxiety Disorders

Start: 2002-06-30End: 2004-08-31Updated: 2012-10-19

Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava

TerminatedNCT05081882

University of FloridaSmoking

Start: 2022-06-09End: 2025-06-30Updated: 2026-09-03

Unknown Phase

Investigation of Kava Effects on NNK Metabolism

CompletedNCT02500472

Masonic Cancer Center, University of MinnesotaTobacco Smoking

Start: 2015-12-03End: 2018-03-31Updated: 2018-04-04

Related Papers

Reducing tobacco-associated lung cancer risk: a study protocol for a randomized clinical trial of AB-free kava

Trials2023-01-182 citations

Quantitative Profiling of Cortisol Metabolites in Human Urine by High-Resolution Accurate-Mass Ms

Bioanalysis2018-11-0620 citations